[Interferon-gamma in pathogenesis of rheumatoid arthritis].
Umehara
Hisanori
H
Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine.
Tanaka
Masao
M
Mimori
Tsuneyo
T
D000276:Adjuvants, Immunologic; D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000209:etiology* / Q000628:therapy; D018925:Chemokines / Q000096:biosynthesis; D002881:Chromosomes, Human, Pair 12 / Q000235:genetics; D006801:Humans; D018836:Inflammation Mediators; D007371:Interferon-gamma / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D007694:Killer Cells, Natural / Q000276:immunology; D011110:Polymorphism, Genetic; D011994:Recombinant Proteins / Q000627:therapeutic use; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology
D000276:Adjuvants, Immunologic; D000906:Antibodies; D018925:Chemokines; D018836:Inflammation Mediators; D011994:Recombinant Proteins; D007371:Interferon-gamma